14
Registered trials
9
Recruiting
4
Completed trials
4
Countries active
25
Unique IMPs
100%
Results reported
100%
4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
Top indications
Top IMPs
(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE
3
FLUDEOXYGLUCOSE (18F)
3
ACICLOVIR
1
ALENDRONATE SODIUM MONOHYDRATE
1
AMIODARONE HYDROCHLORIDE
1
ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350
1
CARIPRAZINE
1
CEFOTAXIME
1
CEFTRIAXONE SODIUM
1
CLINDAMYCIN
1
GEMCITABINE
1
LINEZOLID
1
All trials
14 total-
FAPI PET in Pleural Mesothelioma Recruiting
-
Naldemedine OIBD Recruiting
-
Tramadol OIBD Ended
Showing 1–14 of 14 trials